Health Outcomes from Multidrug-Resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis.

BACKGROUND Salmonella is a leading cause of foodborne enterocolitis worldwide. Antimicrobial use in food animals is the driving force for antimicrobial resistance among Salmonella particularly in high-income countries. Nontyphoidal Salmonella (NTS) infections that are multidrug resistant (MDR) (nonsusceptible to ≥1 agent in ≥3 antimicrobial categories) may result in more severe health outcomes, although these effects have not been systematically examined. We conducted a systematic review and meta-analysis to examine impacts of MDR NTS on disease outcomes in high-income settings. METHODS We systematically reviewed the literature from scientific databases, including PubMed, Scopus, and grey literature sources, using preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. We included peer-reviewed publications of case-control and cohort studies, outbreak investigations, and published theses, imposing no language restriction. We included publications from January 1, 1990 through September 15, 2016 from high-income countries as classified by the World Bank, and extracted data on duration of illness, hospitalization, morbidity and mortality of MDR, and pan-susceptible NTS infections. RESULTS After removing duplicates, the initial search revealed 4258 articles. After further screening, 16 eligible studies were identified for the systematic review, but, only 9 of these were included in the meta-analysis. NTS serotypes differed among the reported studies, but serotypes Typhimurium, Enteritidis, Newport, and Heidelberg were the most often reported MDR pathogens. Salmonella infections that were MDR were associated with excess bloodstream infections (odds ratio [OR] 1.73; 95% confidence interval [CI] 1.32-2.27), more frequent hospitalizations (OR 2.51; 95% CI 1.38-4.58), and higher mortality (OR 3.54; 95% CI 1.10-11.40) when compared with pan-susceptible isolates. CONCLUSIONS Our study suggests that MDR NTS infections have more serious health outcomes compared with pan-susceptible strains. With the emergence of MDR Salmonella strains in high-income countries, it is crucial to reduce the use of antimicrobials in animals and humans, and intervene to prevent foodborne infections.

[1]  T. Barrett,et al.  Hospitalization and Antimicrobial Resistance in Salmonella Outbreaks, 1984–2002 , 2005, Emerging infectious diseases.

[2]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[3]  D. Vugia,et al.  Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in FoodNet sites, 2006-2008. , 2014, Foodborne pathogens and disease.

[4]  T. Jones,et al.  Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. , 2005, The Journal of infectious diseases.

[5]  D. Middleton,et al.  Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. , 2004, The Journal of infectious diseases.

[6]  L. Ng,et al.  Ceftiofur Resistance in Salmonella enterica Serovar Heidelberg from Chicken Meat and Humans, Canada , 2010, Emerging infectious diseases.

[7]  N. Beeching,et al.  A retrospective study of secondary bacteraemia in hospitalised adults with community acquired non-typhoidal Salmonella gastroenteritis , 2013, BMC Infectious Diseases.

[8]  R. Hoekstra,et al.  Antimicrobial Resistance Among Nontyphoidal Salmonella Isolated From Blood in the United States, 2003-2013. , 2015, The Journal of infectious diseases.

[9]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[10]  Peter Gerner-Smidt,et al.  Excess Mortality Associated with Antimicrobial Drug-Resistant Salmonella Typhimurium , 2002, Emerging infectious diseases.

[11]  T. Barrett,et al.  Emergence of Multidrug-Resistant Salmonella enterica Serotype Newport Infections Resistant to Expanded-Spectrum Cephalosporins in the United States , 2003 .

[12]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[13]  D. Walker,et al.  Higher hospital costs and lengths of stay associated with quinolone-resistant Salmonella enterica infections in Hong Kong. , 2010, Journal of public health.

[14]  M. Barza Potential mechanisms of increased disease in humans from antimicrobial resistance in food animals. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  C. Chiu,et al.  Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  M. Gordon Salmonella infections in immunocompromised adults. , 2008, The Journal of infection.

[17]  A. Cronquist,et al.  Antimicrobial use and outcomes in patients with multidrug-resistant and pansusceptible Salmonella Newport infections, 2002-2003. , 2005, Microbial drug resistance.

[18]  Mike Clarke,et al.  Is Evidence-Based Medicine Relevant to the Developing World? , 2005, Evidence-based complementary and alternative medicine : eCAM.

[19]  Gail M. Williams,et al.  Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model. , 2015, Contemporary clinical trials.

[20]  R. Barlow Emerging nontyphoidal salmonella antibiotic resistance in Oregon 2004-2009 : risk factors and trends , 2012 .

[21]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  K. Mølbak,et al.  The interaction between prior antimicrobial drug exposure and resistance in human Salmonella infections. , 2010, The Journal of antimicrobial chemotherapy.

[23]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[24]  S. Zansky,et al.  Multidrug-resistant nontyphoidal Salmonella in New York state's foodborne diseases active surveillance network counties. , 2010, Foodborne pathogens and disease.

[25]  E. K. Maloney,et al.  Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. , 1994, The Journal of infectious diseases.

[26]  J. Barendregt,et al.  A new improved graphical and quantitative method for detecting bias in meta-analysis. , 2018, International journal of evidence-based healthcare.

[27]  J. Kwong,et al.  Emergence of multidrug resistance in locally-acquired human infections with Salmonella Typhimurium in Australia owing to a new clade harbouring blaCTX-M-9. , 2017, International journal of antimicrobial agents.

[28]  P. Fey,et al.  Ceftriaxone-resistant salmonella infection acquired by a child from cattle. , 2000, The New England journal of medicine.

[29]  L. Majtánová,et al.  Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009. , 2010, Diagnostic microbiology and infectious disease.

[30]  S. Chu,et al.  Influence of ciprofloxacin resistance on risk factors for endovascular infection in patients with infection due to group C nontyphoid salmonellae. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Gail M. Williams,et al.  Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model. , 2015, Contemporary clinical trials.

[32]  K. Mølbak,et al.  Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. , 2004, The Journal of infectious diseases.

[33]  S. Holmberg,et al.  Drug-resistant Salmonella from animals fed antimicrobials. , 1984, The New England journal of medicine.

[34]  J. Crump,et al.  Antimicrobial Resistance among Invasive Nontyphoidal Salmonella enterica Isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007 , 2011, Antimicrobial Agents and Chemotherapy.

[35]  P. Hsueh,et al.  Bacteraemia due to ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis in adult patients at a university hospital in Taiwan, 1996–2004 , 2006, Epidemiology and Infection.

[36]  Tine Hald,et al.  World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis , 2015, PLoS medicine.

[37]  M. Tobin-D'Angelo,et al.  Salmonellosis outcomes differ substantially by serotype. , 2008, The Journal of infectious diseases.